Cohort study investigates complication rates in osteochondral autograft versus cell-based treatment, suggesting differing revision needs.
Key Points
Patients undergoing autologous cell-based cartilage treatment are more likely to need revision surgery compared to those receiving osteochondral autograft treatment.
In a cohort analysis involving 1298 patients, the revision surgery rate was 11.1% for the autologous treatment group versus 7.4% for the autograft.
No significant differences were found in progression to osteoarthritis (11.4% vs 10.6%) or knee arthroplasty between treatment groups.
The results indicate a need for further studies on long-term outcomes and symptom progression for these cartilage restoration techniques.